Dr Reddy’s stock plunges 10% over US FDA action

Dr Reddy's Laboratories tumbled 10% in morning trade with investors dumping the stock as more detailed analysis emerged of warnings received earlier in the month from the US Food and Drug Administration over manufacturing practices.